Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
218 studies found for:    "Idiopathic pulmonary fibrosis"
Show Display Options
Rank Status Study
21 Active, not recruiting Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: inhaled carbon monoxide;   Other: Oxygen
22 Recruiting Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
23 Completed Safety and Tolerability Study of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: FG-3019
24 Completed Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: bosentan;   Drug: Placebo
25 Recruiting Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: ART-123;   Drug: Placebo
26 Terminated 68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Procedure: 68Ga-DOTA-NOC PET/CT
27 Unknown  Azathioprine and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Placebo;   Drug: AZAPRED
28 Completed Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Pulmonary rehabilitation
29 Recruiting A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: KD025;   Drug: Standard of Care
30 Active, not recruiting Integrating Palliative Care for Patients With Idiopathic Pulmonary Fibrosis and Their Caregivers
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Other: Enhanced patient educational material and support;   Other: Currently available printed patient material
31 Terminated
Has Results
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: warfarin;   Drug: placebo
32 Completed
Has Results
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Bosentan
33 Completed First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: GSK3008348 Nebuliser solution;   Drug: Placebo Nebuliser solution;   Radiation: GSK26346763: ([18F]-FBA-A20FMDV2) IV infusion
34 Completed Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: octreotide
35 Completed Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: zileuton;   Drug: azathioprine/prednisone
36 Completed Reliability of the 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: 4MGS
37 Recruiting 68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: 68Ga-BMV101
38 Active, not recruiting Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
39 Not yet recruiting A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Valganciclovir;   Drug: Placebo
40 Terminated Long-Term Safety Study of GS-6624 to Treat Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Simtuzumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.